JK

Jitender Kumar

Director DIN 03572064
DIN 03572064 First appointment Jul 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitender Kumar

Data last updated:

Jitender Kumar was an Additional Director at Fauna Regenerations Private Limited (from 2016) and Director at Novo Elixir Biotech Private Limited (from 2011).

DIN 03572064
First Appointment 14 Jul 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fauna Regenerations Private Limited U74140RJ2013PTC043353
Additional Director29 Aug 20162013Strike Off
Novo Elixir Biotech Private Limited U73200PB2011PTC035281
Director14 Jul 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fauna Regenerations Private Limited
Novo Elixir Biotech Private Limited
Premium access

Shareholding and investment profile for Jitender Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitender Kumar

Jitender Kumar was first appointed on 14 Jul 2011 as Director at Novo Elixir Biotech Private Limited. The most recent appointment on record is 29 Aug 2016 at Fauna Regenerations Private Limited.

Jitender Kumar held 2 earlier board appointments: Fauna Regenerations Private Limited (Additional Director, from 29 Aug 2016); Novo Elixir Biotech Private Limited (Director, from 14 Jul 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available